Oblique Therapeutics AB (publ.)
www.obliquet.comOblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and advanced cancer. The company uses Abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.
Read more
Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and advanced cancer. The company uses Abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.
Read more
Country
City (Headquarters)
Göteborg
Industry
Employees
11-50
Founded
2015
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Development Officer
Email ****** @****.comPhone (***) ****-****Member of the Board
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chief Business Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(1)
Reach decision makers at Oblique Therapeutics AB (publ.)
Free credits every month!
Oblique Therapeutics AB (publ.) FAQ
Göteborg, Sweden
Biotechnology Research
